Catalyst Wire Dossier Catalyst Wire Dossier

Lacidipine/Telmisartan fixed-dose combination tablet

Lacidipine; Telmisartan · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lacidipine/Telmisartan fixed-dose combination tablet, covering 2014-08-06 to 2014-08-06. Get the full timeline:

Most recent: Clinical Trial Update: Bioavailability of Lacidipine and Telmisartan Fixed Dose Combination Tablets Relative to Separate Tablets in Healthy Subjects [Phase 1]

See pricing